Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters.
about
Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeuticsFluoxetine Increases the Expression of miR-572 and miR-663a in Human Neuroblastoma Cell LinesDexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patientsFluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanismXenobiotic, bile acid, and cholesterol transporters: function and regulation.Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.Neuroplasticity and major depression, the role of modern antidepressant drugsClinical and biological effects of mifepristone treatment for psychotic depression.Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axisInteractions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.A placebo-controlled study of sertraline's effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adultsInhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats.Glucocorticoid receptor function in vitro in patients with major depression.Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression.The glucocorticoid receptor: part of the solution or part of the problem?Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatmentAre BDNF and glucocorticoid activities calibrated?In vitro modulation of the glucocorticoid receptor by antidepressants.Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder.Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.The glucocorticoid receptor: pivot of depression and of antidepressant treatment?A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice.Desipramine treatment has minimal effects on the brain accumulation of glucocorticoids in P-gp-deficient and wild-type mice.Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad.Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor.In vitro and in vivo evaluation of the effects of duloxetine on P-gp function.The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria.Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line.Central nervous system (CNS) delivery of glucocorticoids is fine-tuned by saturable transporters at the blood-CNS barriers and nonbarrier regions.Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.[The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression].Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine.Effect of sertraline on glucocorticoid sensitivity of mononuclear leukocytes in post-traumatic stress disorder.Reversal of reduced parvalbumin neurons in hippocampus and amygdala of Angelman syndrome model mice by chronic treatment of fluoxetine.Co-administration of Fluoxetine Alters the Steady State Pharmacokinetics of Fluconazole after Multiple Oral Administration in Dogs
P2860
Q24618470-C3FC173B-13A4-4F51-8767-C707C1081105Q28554574-17C6422D-31BC-4AC1-94E2-7E4173ED82CDQ30455078-F8438D36-07F8-4C8D-9FA9-D2C45104A4D3Q30588606-12A7962D-5C57-49BE-BE91-4A53F5271B57Q33714593-DFC7914A-2E18-4422-BC26-370F6C3FBB74Q34315494-167536BC-ACCC-40ED-A381-E4DBC5454A95Q34381499-FD10986C-9186-41D7-A468-9576424B5E00Q34450697-713BB48D-183E-4C41-8500-4188D996424CQ35271933-2493A864-B48C-4AA9-B48A-757C0698EF95Q35708089-DF20F13A-25FC-4DB8-B5B5-6705A1DC965EQ35743599-42317090-2650-44AD-A841-64BEC0142BB3Q36159042-1DF9CD0B-7802-4FB8-B03D-3C04FEB5D128Q36194741-AA38F111-10DC-45A3-8411-34A9AA5BFE71Q36442038-328B46C5-E149-48E1-BA6A-9C1C869E2EC1Q36511702-16BBFD46-4CF3-44C0-9356-E9DC4B172142Q36610037-44640323-3B16-4416-BA27-4FE76D1B3D78Q36636661-C909B666-C6D8-4DE4-A4FC-4ADD6E533745Q37344256-A5B175E4-A900-4BE6-953A-E0AF04CAE1FDQ37375170-DCC65CCB-FD1C-44B6-AF9A-B0093C5EB77FQ37631141-3ECED0E4-E2D6-48C6-AEFF-41407C192CDBQ37732806-95524F5F-98D9-4C16-8D38-50E86943384CQ38290046-0A3559B8-3495-4A6C-9EFC-B7A5910125D0Q38560579-8D3C8244-19E0-4B79-A5C3-E6D989A13AA3Q39305340-DC9D416F-CD0A-41DE-95FE-F3FBFE901E40Q39560411-470D8C5B-1C1B-464E-BB64-86BA6D826030Q39594120-F6AF8E37-F5E5-406C-B422-A20DEFFBBFFBQ39625453-4977E486-51F9-4F80-B4D9-9BB5A1BDB2A2Q39906257-CAA9F75C-ADE6-4CAC-80E6-434AF75E4D7AQ41811241-65636BF1-B8D0-43F1-8710-8A4C0EDCC0BFQ44858854-102DC90D-B0A1-4F1C-9800-1BE2FB426E04Q45220473-9F3E1082-6D7D-49C5-B306-BCF8BF81015CQ46237114-AF036C16-8699-4D4E-AE93-6C7935E2839AQ46670491-C6ACE645-FFFE-4CC0-8751-4A5F5FD7A5D6Q47785030-F1D49771-234C-4BB7-B33C-4F11AEF6C09CQ58647372-0490A42B-ED71-4240-BBDC-29BFD0A1B29E
P2860
Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Antidepressant fluoxetine enha ...... membrane steroid transporters.
@en
type
label
Antidepressant fluoxetine enha ...... membrane steroid transporters.
@en
prefLabel
Antidepressant fluoxetine enha ...... membrane steroid transporters.
@en
P2093
P2860
P356
P1476
Antidepressant fluoxetine enha ...... membrane steroid transporters.
@en
P2093
Andrew Makoff
Richard B Kim
Robert W Kerwin
P2860
P304
P356
10.1038/SJ.BJP.0705357
P407
P577
2003-07-01T00:00:00Z